Macular degeneration is the progressive deterioration of a critical region of the retina called the macula. The macula is a 3-5 mm area in the retina that is responsible for central vision. This disorder leads to irreversible loss of central vision, although peripheral vision is retained. In the early stages, vision may be gray, hazy, or distorted.
Researchers looked at a UK sample of patients with AMD and controls, and screened 32 genes potentially involved in the condition. Results suggest an association with the SERPING1 gene. – A new genetic association is established with the eye condition age-related macular degeneration (AMD), revealed by researchers.
Eating oily fish once weekly may protect eyesight against age-related macular degeneration in old age. – Eating oily fish once a week may reduce age-related macular degeneration (AMD) which is the major cause of blindness and poor vision in adults in western countries and the third cause of global blindness, according to a study published in the American Journal of Clinical Nutrition.
Two major eye diseases and leading causes of blindness?age-related macular degeneration and diabetic retinopathy?can be reversed or even prevented by drugs that activate a protein found in blood vessel cells. – Two major eye diseases and leading causes of blindness-age-related macular degeneration and diabetic retinopathy-can be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other institutions have announced in a new study.
A University of Southampton research team, led by Professor Andrew Lotery, has identified a new genetic risk factor for age-related macular degeneration (AMD), a major cause of untreatable blindness in elderly people in developed countries. – A University of Southampton research team, led by Professor Andrew Lotery, has identified a new genetic risk factor for age-related macular degeneration (AMD), a major cause of untreatable blindness in elderly people in developed countries.
UF scientists are testing the safety of experimental drug Compstatin for vision loss in macular degeneration patients. – University of Florida UF scientists are testing the safety of experimental drug Compstatin for vision loss in macular degeneration patients. In a first-of-its-kind safety research study, University of Florida researchers have injected an anti-inflammatory compound into the eye of a person with a sight-robbing disease.
